Citadel Advisors’s Hinge Health HNGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.43M Sell
76,380
-681,730
-90% -$59.8M ﹤0.01% 4155
2026
Q2
$62.9M Sell
758,110
-325,605
-30% -$17.7M 0.01% 1347
2026
Q1
$41.8M Buy
1,083,715
+577,611
+114% +$24M 0.01% 1528
2025
Q4
$23.5M Buy
506,104
+437,276
+635% +$21.1M ﹤0.01% 2167
2025
Q3
$3.38M Sell
68,828
-163,041
-70% -$8.53M ﹤0.01% 5082
2025
Q2
$12M Buy
+231,869
New +$9.37M ﹤0.01% 2777

Other funds holding HNGE

Citadel Advisors's HNGE Position: Q3 2026 in Review

Citadel Advisors reduced its Hinge Health (HNGE) stake by 90% in Q3 2026, selling an estimated $59.8M and leaving 76,380 shares worth $7.43M. The position accounts for ﹤0.01% of the portfolio, ranked #4155.

Citadel Advisors first reported a position in HNGE in Q2 2025 and has held it in 6 quarters since. The position peaked at $62.9M in Q2 2026. 368 funds tracked by Wall St. Rank hold HNGE as of Q3 2026.

  • Citadel Advisors held 76,380 shares of Hinge Health worth $7.43M as of Q3 2026.
  • Citadel Advisors sold 681,730 Hinge Health shares in Q3 2026, an estimated $59.8M.
  • Hinge Health made up ﹤0.01% of Citadel Advisors's portfolio in Q3 2026, its #4155 holding.
  • Citadel Advisors first reported a position in Hinge Health in Q2 2025 and has held it in 6 quarters since.
  • Citadel Advisors's Hinge Health position peaked at $62.9M in Q2 2026.
  • 368 funds tracked by Wall St. Rank held Hinge Health as of Q3 2026.

Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.